Advertisement

Topics

Bioverativ Inc. & Sobi Company Profile

12:53 EDT 20th October 2018 | BioPortfolio

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 following separation from Biogen Inc., Bioverativ builds upon a strong heritage of scientific innovation and is committed to actively working with the blood disorders community. The company’s mission is to create progress for patients where they need it most and its hemophilia therapies when launched represented the first major advancements in hemophilia treatment in more than two decades. For more information, visit www.bioverativ.com or follow @bioverativ on Twitter.


News Articles [54 Associated News Articles listed on BioPortfolio]

Bioverativ Highlights the Impact of Humanitarian Aid in Hemophilia

More than 15,000 people with hemophilia in 40 developing countries have already been treated following Bioverativ and Sobi’s unprecedented donation of factor therapy to the WFH ...

Bioverativ Presents Preliminary Phase 1/2a Data on BIVV001, the First Factor VIII Therapy to ...

Bioverativ is now exploring twice-a-month dosing with BIVV001, which could transform the treatment paradigm in hemophilia A Read more...

Sobi värvar chef från Pfizer

Fredrik Wetterlundh blir ny HR-chef på Sobi.

EU expands indications for Sobi's Kineret

European regulators expanded treatment indications for Sobi's Kineret, or anakinra, to treat the rare auto-inflammatory disor -More- 

EU regulators expand reach of Sobi’s Kineret

European regulators have expanded the scope of Sobi’s Kineret to include the treatment of Still’s disease, a rare, systemic, multi-organ, auto-inflammatory disorder that affects around 25,...

Sobi secures NHS reimbursement for Ravicti

Rare disease group Swedish Orphan Biovitrum (Sobi) says it has gained NHS England reimbursement for Ravicti for long-term management of urea-cycle disorders (UCDs) in adults and children.

#news #biotech Bioverativ executive Rogerio Vivaldi to helm cell therapy producer Sigilon

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bioverativ executive Rogerio Vivaldi to helm cell therapy producer Sigilon .S...

Sobi licenses HLH candidate emapalumab from Novimmune

Novimmune SA granted Swedish Orphan Biovitrum AB (Sobi) exclusive global rights to emapalumab, an interferon gamma antagonist awaiting approval for primary haemophagocytic lymphohitiocytosis (HLH). (S...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [8 Associated Companies listed on BioPortfolio]

Bioverativ Inc. & Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class re...

Bioverativ Inc. and Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class re...

Swedish Orphan Biovitrum AB

Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. Sobi have a diversi...

Bioverativ Inc.

Bioverativ (NASDAQ: BIVV) is a global biotechnology company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class resear...

Sobi

Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the li...

More Information about "Bioverativ Inc. & Sobi" on BioPortfolio

We have published hundreds of Bioverativ Inc. & Sobi news stories on BioPortfolio along with dozens of Bioverativ Inc. & Sobi Clinical Trials and PubMed Articles about Bioverativ Inc. & Sobi for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bioverativ Inc. & Sobi Companies in our database. You can also find out about relevant Bioverativ Inc. & Sobi Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record